CNBC's Courtney Reagan reports Moody's put Belgium on review for a possible downgrade; U.S. consumers have drastically cut their borrowing; and Merck's Juvisync won FDA approval for the treatment of diabetes and high cholesterol.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT